FAQ/Help |
Calendar |
Search |
Today's Posts |
08-24-2018, 06:21 PM | #1 | ||
|
|||
Member
|
Phase 2 Trial Shows Nilotinib Potential to Modulate Dopamine in Parkinson’s
Phase 2 Trial Shows Nilotinib Potential to Modulate Dopamine in Parkinson’s |
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
Gocovri Improves Dyskinesia in Parkinson’s Patients Over Long Term, Phase 3 Trial | Parkinson's Disease | |||
MRI-Focused Ultrasound Undergoing Phase 3 Clinical Trial for Parkinson’s Treatment | Parkinson's Disease | |||
Phase 2 Trial Testing Leukemia Treatment, Nilotinib | Parkinson's Disease | |||
Voyager’s Gene Therapy to Enter Phase 2/3 Trial Program for Adv Parkinson’s Dise | Parkinson's Disease | |||
Recruitment has begun for the Georgetown University "PD Nilotinib" phase 2 trial | Parkinson's Disease |